SOURCE-LINKED INTELLIGENCE

ARTIFICIAL INTELLIGENCE STRATEGIES FOR ALZHEIMER'S DISEASE RESEARCH - ALZHEIMER'S DISEASE (AD) IS A COMMON DISEASE THAT IS PARTLY DUE TO PROTEIN MISFOLDING AND AGGREGATION. RESEARCH ON AD IS A NATIONAL PRIORITY WITH 5.5

USAspending · observation · Publication date unknown

ARTIFICIAL INTELLIGENCE STRATEGIES FOR ALZHEIMER'S DISEASE RESEARCH - ALZHEIMER'S DISEASE (AD) IS A COMMON DISEASE THAT IS PARTLY DUE TO PROTEIN MISFOLDING AND AGGREGATION. RESEARCH ON AD IS A NATIONAL PRIORITY WITH 5.5 MILLION AMERICANS AFFECTED AT AN ANNUAL COST OF MORE THAN $250 BILLION AND NO AVAILABLE CURE. THIS IS DESPITE HEAVY INVESTMENTS IN THE COLLECTION OF DIVERSE CLINICAL AND BIOLOGICAL DATA IN EXPERIMENTAL AND POPULATION-BASED STUDIES. ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING HAVE THE POTENTIAL TO REVEAL PATTERNS IN CLINICAL AND MULTI-SOURCE LARGE-SCALE ALZHEIMER’S DATA TH

Read original source ↗ Open in workspace

recordType

award

region

US

value

6749268

unit

USD